ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Lithium hexamethyldisilazane → (3s)-Tert-butyl 4-((1r)-1-(6-(5-fluoro-6-methoxypyridin-3-ylamino)-5-(2-methyl-9-(tetrahydro-2h-pyran-2-yl)-9h-purin-6-yl)pyridin-3-yl)ethyl)-3-methylpiperazine-1-carboxylate

HRID 1812265
印刷

反応式

HRID 1812265 の反応式
F[C:2]1[N:7]=[CH:6][C:5]([C@H:8]([N:10]2[CH2:15][CH2:14][N:13]([C:16]([O:18][C:19]([CH3:22])([CH3:21])[CH3:20])=[O:17])[CH2:12][C@@H:11]2[CH3:23])[CH3:9])=[CH:4][C:3]=1[C:24]1[N:32]=[C:31]([CH3:33])[N:30]=[C:29]2[C:25]=1[N:26]=[CH:27][N:28]2[CH:34]1[CH2:39][CH2:38][CH2:37][CH2:36][O:35]1.[F:40][C:41]1[CH:42]=[C:43]([NH2:49])[CH:44]=[N:45][C:46]=1[O:47][CH3:48].C[Si]([N-][Si](C)(C)C)(C)C.[Li+]>C1COCC1>[F:40][C:41]1[CH:42]=[C:43]([NH:49][C:2]2[N:7]=[CH:6][C:5]([C@H:8]([N:10]3[CH2:15][CH2:14][N:13]([C:16]([O:18][C:19]([CH3:21])([CH3:20])[CH3:22])=[O:17])[CH2:12][C@@H:11]3[CH3:23])[CH3:9])=[CH:4][C:3]=2[C:24]2[N:32]=[C:31]([CH3:33])[N:30]=[C:29]3[C:25]=2[N:26]=[CH:27][N:28]3[CH:34]2[CH2:39][CH2:38][CH2:37][CH2:36][O:35]2)[CH:44]=[N:45][C:46]=1[O:47][CH3:48]
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 2733832Lithium hexamethyldisilazaneHCID 454803515-Fluoro-6-methoxypyridin-3-amineHCID 68511317(3S)-tert-butyl 4-((1R)-1-(6-fluoro-5-(2-methyl-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)pyridin-3-yl)ethyl)-3-methylpiperazine-1-carboxylate

生成物 1

HCID 68516009(3s)-Tert-butyl 4-((1r)-1-(6-(5-fluoro-6-methoxypyridin-3-ylamino)-5-(2-methyl-9-(tetrahydro-2h-pyran-2-yl)-9h-purin-6-yl)pyridin-3-yl)ethyl)-3-methylpiperazine-1-carboxylate
収率 39.1%

試薬・触媒・溶媒 1

HCID 8028Tetrahydrofuran溶媒

反応条件

温度
-20 °C

実験手順

A mixture of (3S)-tert-butyl 4-((1R)-1-(6-fluoro-5-(2-methyl-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)pyridin-3-yl)ethyl)-3-methylpiperazine-1-carboxylate (0.323 g, 0.599 mmol) and 5-fluoro-6-methoxypyridin-3-amine (0.170 g, 1.197 mmol) in THF (15 mL) was chilled to −20° C. in a diluted dry ice/acetone bath, then lithium bis(trimethylsilyl)amide (1.0 M in THF, Aldrich; 1.796 mL, 1.796 mmol) was added slowly via syringe into the reaction mixture. After the addition, the ice bath was removed and the mixture was allowed to stir under inert atmosphere for 1 h. The mixture was diluted with chloroform (20 mL) and water (10 mL). The organic layer was extracted with chloroform (3×10 mL). The combined organic extracts were dried over sodium sulfate, filtered and concentrated in vacuo. The crude material was adsorbed onto silica gel and purified by chromatography through a silica-gel column (80 g) eluting with 100% EtOAc to give (3S)-tert-butyl 4-((1R)-1-(6-(5-fluoro-6-methoxypyridin-3-ylamino)-5-(2-methyl-9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-yl)pyridin-3-yl)ethyl)-3-methylpiperazine-1-carboxylate (0.155 g, 0.234 mmol, 39.1% yield) as a tan solid. 1H NMR (400 MHz, CDCl3) δ 12.63 (s, 1H) 9.71 (d, J=2.15 Hz, 1H) 8.32 (dd, J=12.52, 2.15 Hz, 1H) 8.22 (s, 1H) 8.17 (d, J=2.35 Hz, 1H) 8.03 (d, J=2.15 Hz, 1H) 5.80 (dd, J=10.56, 2.15 Hz, 1H) 4.12 (s, 2H) 3.96 (s, 3H) 3.76 (d, J=2.54 Hz, 1H) 3.53 (m, 1H) 3.23 (m, 1H) 2.84 (s, 5H) 2.41 (m, 1H) 2.08 (s, 1H) 2.03 (s, 1H) 1.97 (s, 1H) 1.64 (s, 3H) 1.58 (s, 2H) 1.45 (d, J=6.85 Hz, 3H) 1.32 (s, 9H) 1.07 (d, J=5.87 Hz, 3H). m/z (ESI, +ve ion) 662.2 (M+H)+.

後処理

  1. additionAfter the addition
  2. customthe ice bath was removed
  3. additionThe mixture was diluted with chloroform (20 mL) and water (10 mL)
  4. extractionThe organic layer was extracted with chloroform (3×10 mL)
  5. dry with materialThe combined organic extracts were dried over sodium sulfate
  6. filtrationfiltered
  7. concentrationconcentrated in vacuo
  8. custompurified by chromatography through a silica-gel column (80 g)
  9. washeluting with 100% EtOAc

出典と根拠

ORDレコード
ord-021bcffec77646c2ba959531aabac048
出典データセット
uspto-grants-2013_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08362241B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート